Most-Favored-Nation Drug Pricing and Its Clinical Impact

Most-Favored-Nation (MFN) drug pricing sounds simple on paper: tie what the U.S. pays for certain drugs to the lowest price available in comparable countries. And the motivation is real. In 2022, U.S. prescription drug prices were 2.78× those in 33 other OECD countries; for brand-name drugs, U.S. prices were more than 3× higher. The U.S. […]

GLP-1s, Weight Loss Drugs, and the New Metabolic Care Conversation

GLP-1 medications have completely changed the way many patients and clinicians think about weight and metabolic health. Agents like semaglutide and tirzepatide have moved from specialist conversations into everyday primary care, fueled by striking clinical trial results and constant media coverage. Patients often arrive with stories of friends or celebrities who “lost 30 pounds” and […]

Why AI and Healthcare Technology Can Fail Without Clinicians at the Table

I have always been someone who loves technology and is genuinely excited by what it can do for medicine. The promise of better efficiency, safer care, and more time with patients is hard not to believe in. Over the years, though, I have watched that promise fall short far too often. Again and again, I […]

How AI Is Changing Cancer Conversations Between Oncologists and Patients

–Normalize early. Ask upfront: “What did AI tell you?” This surfaces misconceptions efficiently before they drive anxiety or derail the visit.  –Reframe AI’s role. Position AI as a conversation starter, not a second opinion. You bridge the gap between generic outputs and their individualized care plan.  –Partner, don’t scold. Applaud engagement while gently correcting misinformation. […]

How TrumpRx and GoodRx Could Reshape Drug Pricing – And What Clinicians Should Know

Drug pricing reform usually feels like something happening far from daily practice–important but abstract. The TrumpRx initiative changes that immediately. By introducing a federal portal that displays government-negotiated cash prices, it turns drug costs into a decision patients manage directly, sometimes before they even speak to a clinician. Instead of navigating co-pays, deductibles, or complex […]